Politico July 1, 2024
By Chelsea Cirruzzo and Ben Leonard

Driving the Day

HOW CHEVRON COULD SLOW THE FDA — A Friday Supreme Court ruling could mean it will take longer to develop new drugs and medical devices, former FDA attorneys say.

The Supreme Court overturned a Reagan-era precedent, called the Chevron deference, which required judges to defer to federal agencies’ interpretations of ambiguous federal laws.

The White House said the rule takes the country “backwards” and could “thwart efforts to respond to a global pandemic.”

The ruling could also mean new court challenges for the Biden administration’s Medicare drug negotiation policy and more pressure on Congress and the federal courts to hone their knowledge of health policy.

Slowed response time: The former FDA attorneys worry that the FDA’s process...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
2025 Pharma Forecast: Four Pivotal Trends Revolutionizing Market Access Strategies
Christophe Weber, veteran Takeda CEO, to retire next year
Walmart To Expand Same-Day Prescription Delivery Nationwide
Podcast: Market Failures, Lessons or Opportunities? 1/30/25
FDA warns GLP-1 compounder over safety rules

Share This Article